Adastra Holdings LtdCanadian Securities Exchange:XTRXView on Over The Counter Market
- LAST PRICE0.2200
- TODAY'S CHANGE (%)0.0250 (12.8205%)
- Bid / Lots0.1900/ 1
- Ask / Lots0.2200/ 1
- Open / Previous Close0.2250 / 0.1950
- Day Range
- 52 Week Range
- Volume1,246
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XTRX |
|---|
May 1, 2024
Adastra Announces Intention to Terminate SEC Reporting Obligations, from 5:03PM ET on Wednesday May 01, 2024 by Dow Jones
5:03PM ET on Wednesday May 01, 2024 by Dow Jones
Apr 23, 2024
ADASTRA HOLDINGS REPORTS FY2023 RESULTS; MARKING THIRD CONSECUTIVE YEAROF RECORD REVENUE, from 8:23PM ET on Tuesday Apr 23, 2024 by Dow Jones
8:23PM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 15, 2024
Adastra Holdings Announces Lachlan McLeod as Interim CEO, from 5:31PM ET on Monday Apr 15, 2024 by Dow Jones
5:31PM ET on Monday Apr 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Adastra Holdings Ltd | 12.3M | -3.5x | --- |
CanadaBis Capital Inc | 9.7M | 3.0x | --- |
Lifeist Wellness Inc | 3.0M | -0.2x | --- |
Avant Brands Inc | 24.2M | -2.9x | --- |
Ionic Brands Corp | 689.4K | 0.0x | --- |
Heritage Cannabis Holdings Corp | 5.3M | -0.2x | --- |
Company Information
Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products. The Company serves medical markets and is engaged in therapeutic applications. The Company’s Phyto Extractions and Endgame Extracts brands distribute cannabis concentrate products through retailers at approximately 2,000 locations across Canada. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. It partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., Chemia Analytics Inc., 1225140 B.C. Ltd and 1204581 B.C. Ltd.
Contact Information
- Headquarters
- 5451 - 275 StreetLANGLEY, BC, Canada V4W 3X8
- Phone
- 778-715-5011
- Fax
- 604-687-7828
Executives
- Interim Chief Executive Officer, Chief Financial Officer, Company Secretary
- Lachlan Mcleod
- Director
- Jon Edwards
- Independent Director
- Paul Morgan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.3M |
|---|---|
Revenue (TTM) | $22.2M |
Shares Outstanding | 56.0M |
Adastra Holdings Ltd does not pay a dividend. | |
Beta | -0.36 |
EPS | $-0.06 |
Book Value | $0.26 |
P/E Ratio | -3.5x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13.13% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
